These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9039510
1. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome. Schmitt K, Häusler G, Blümel P, Plöchl E, Waldhör T, Frisch H. Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510 [Abstract] [Full Text] [Related]
2. Treatment of patients with Ullrich-Turner syndrome with conventional doses of growth hormone and the combination with testosterone or oxandrolone: effect on growth, IGF-I and IGFBP-3 concentrations. Haeusler G, Frisch H, Schmitt K, Blümel P, Plöchl E, Zachmann M, Waldhör T. Eur J Pediatr; 1995 Jun; 154(6):437-44. PubMed ID: 7545577 [Abstract] [Full Text] [Related]
3. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H. J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264 [Abstract] [Full Text] [Related]
4. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. Stahnke N, Keller E, Landy H, Serono Study Group. J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177 [Abstract] [Full Text] [Related]
5. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum. Scriba PC, Bauer M, Emmert D, Fateh-Moghadam A, Hofmann GG, Horn K, Pickardt CR. Acta Endocrinol (Copenh); 1979 Aug; 91(4):629-43. PubMed ID: 115194 [Abstract] [Full Text] [Related]
6. Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both. Wilson DM, Frane JW, Sherman B, Johanson AJ, Hintz RL, Rosenfeld RG. J Pediatr; 1988 Feb; 112(2):210-7. PubMed ID: 3276862 [Abstract] [Full Text] [Related]
7. [Effects of various contraceptives on laboratory parameters in diagnosis of thyroid gland function with special reference to the free hormones FT4 and FT3]. Sorger D, Schenk S, Schneider G. Z Gesamte Inn Med; 1992 Feb; 47(2):58-64. PubMed ID: 1585690 [Abstract] [Full Text] [Related]
8. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. J Pediatr; 1998 Feb; 132(2):319-24. PubMed ID: 9506648 [Abstract] [Full Text] [Related]
9. Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty. Crowne EC, Wallace WH, Moore C, Mitchell R, Robertson WH, Holly JM, Shalet SM. Clin Endocrinol (Oxf); 1997 Feb; 46(2):209-16. PubMed ID: 9135704 [Abstract] [Full Text] [Related]
10. Growth hormone treatment in Turner's syndrome: short and long-term effects on metabolic parameters. Haeusler G, Frisch H. Clin Endocrinol (Oxf); 1992 Mar; 36(3):247-53. PubMed ID: 1563078 [Abstract] [Full Text] [Related]
11. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome. Menke LA, Sas TC, Visser M, Kreukels BP, Stijnen T, Zandwijken GR, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM, Cohen-Kettenis PT. Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349 [Abstract] [Full Text] [Related]
12. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome. Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM. J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614 [Abstract] [Full Text] [Related]
14. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone. Bareille P, Massarano AA, Stanhope R. Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976 [Abstract] [Full Text] [Related]
15. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome. Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM. J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421 [Abstract] [Full Text] [Related]
17. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J. Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor I alters peripheral thyroid hormone metabolism in humans: comparison with growth hormone. Hussain MA, Schmitz O, Jorgensen JO, Christiansen JS, Weeke J, Schmid C, Froesch ER. Eur J Endocrinol; 1996 May; 134(5):563-7. PubMed ID: 8664976 [Abstract] [Full Text] [Related]
19. Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome. Massa G, de Zegher F, Vanderschueren-Lodeweyckx M. Clin Endocrinol (Oxf); 1991 Mar; 34(3):205-9. PubMed ID: 2036729 [Abstract] [Full Text] [Related]